We are live on ! Find out more
VIVS

VivoSim Labs

109 hedge funds and large institutions have $50.9M invested in VivoSim Labs in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

22% more call options, than puts

Call options by funds: $71K | Put options by funds: $58K

22% more capital invested

Capital invested by funds: $41.8M → $50.9M (+$9.13M)

0.02% more ownership

Funds ownership: 0.16%0.18% (+0.02%)

4% less funds holding

Funds holding: 114109 (-5)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

Holders
109
Holders Change
-5
Holders Change %
-4.39%
% of All Funds
2.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
31
Reduced
15
Closed
16
Calls
$71K
Puts
$58K
Net Calls
+$13K
Net Calls Change
+$37K
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$139K -$2.77K -11 -2%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$121K +$114K +454 +825%
LPL Financial
28
LPL Financial
California
$114K +$755 +3 +0.6%
JMPWA
29
JP Morgan Private Wealth Advisors
California
$113K +$252 +1 +0.2%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$91K +$49.6K +197 +105%
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$89K
AllianceBernstein
32
AllianceBernstein
Tennessee
$88K -$12.1K -48 -12%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$85K
AIG
34
American International Group
New York
$76K +$1.51K +6 +2%
RJFSA
35
Raymond James Financial Services Advisors
Florida
$67K -$2.77K -11 -4%
AG
36
Advisor Group
Arizona
$51K
Citadel Advisors
37
Citadel Advisors
Florida
$49K -$125K -496 -71%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$39K
Two Sigma Investments
39
Two Sigma Investments
New York
$39K +$41K +163 New
AFG
40
Albion Financial Group
Utah
$38K
RJA
41
Raymond James & Associates
Florida
$36K +$17.9K +71 +88%
Citigroup
42
Citigroup
New York
$35K -$755 -3 -2%
Barclays
43
Barclays
United Kingdom
$34K +$35.5K +141 New
HighTower Advisors
44
HighTower Advisors
Illinois
$32K +$1.01K +4 +3%
PAG
45
Private Advisor Group
New Jersey
$31K
JP Morgan Chase
46
JP Morgan Chase
New York
$30K -$504 -2 -2%
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$28K
CS
48
Credit Suisse
Switzerland
$28K +$8.81K +35 +42%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$26.4K +$26.2K +104 +1,486%
Goldman Sachs
50
Goldman Sachs
New York
$25K +$3.02K +12 +13%

VIVS Hedge Fund Activity: Q1 2019 in Review

109 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2019, worth a combined $50.9M — up 22% from $41.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of VIVS and 12 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 31 added.

The largest buyer was Nikko Asset Management Americas, adding an estimated $2.08M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $293K sold.

  • 109 institutional investors held VivoSim Labs (VIVS) as of Q1 2019, down from 114 in Q4 2018.
  • Funds reported $50.9M of VivoSim Labs stock for Q1 2019, up 22% quarter-over-quarter.
  • 12 funds opened new VivoSim Labs positions in Q1 2019 and 16 closed out, a net change of -4 holders.
  • The largest VivoSim Labs buyer in Q1 2019 was Nikko Asset Management Americas, an estimated $2.08M added.
  • The largest VivoSim Labs seller in Q1 2019 was Susquehanna International Group, an estimated $293K sold.

Based on aggregated 13F filings for Q1 2019.